VAP-40 tablets


Each Enteric Coated  tablet contains
Pantoprazole Sodium IP…………… 40 mg


Short-Term Treatment of Erosive Esophagitis Associated With Gastro esophageal  Reflux Disease (GERD)
VAP 40 is indicated for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis.
VAP is indicated for maintenance of healing of erosive Esophagitis Controlled studies did not extend beyond 12 months.
Zollinger-Ellison Syndrome


One Tablet of VAP- 40  swallowed whole, with or without food in the stomach
The recommended adult oral dose is 40 mg given once daily for up to 8 weeks. For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered.
Maintenance of Healing of Erosive Esophagitis
Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome
The dosage of pantoprazole in patients with pathological hypersecretory conditions varies with the individual patient. The recommended adult starting dose is 40 mg twice daily. Dosage regimens should be adjusted to individual patient needs and should continue for as long as clinically indicated. Doses up to 240 mg daily have been administered. Some patients have been treated continuously with pantoprazole for more than 2 years.
No dosage adjustment is necessary in patients with renal impairment, hepatic impairment, or for elderly patients. Doses higher than 40 mg/day have not been studied in hepatically-impaired patients. No dosage adjustment is necessary in patients undergoing hemodialysis.


Pantoprazole is contraindicated in patients with known hypersensitivity to any component of the formulation.

Packaging Information 

VAP  40 tablets …………… Strip of 10 tablets